RxDoctor Payments Data

Nicholas Gidosh

Philadelphia, PANPI 1881081461

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,801 of the $90,219 with a category attached, or 69.6%. Bausch & Lomb Americas Inc. accounts for 61.8% of it on its own, with 9 other manufacturers making up the rest.

$90,219in general payments, 2019–2025

Across 153 payments — averaging $589.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$56K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$32K
  • Alcon$2K
  • Johnson & Johnson Vision Care, Inc.$230
  • Coopervision Inc.$220
  • AbbVie$48
  • plus $85 from 4 others

What the payments were for

  • Consulting fees$14,25116%
  • Speaking & faculty fees$62,80170%
  • Travel & lodging$10,46712%
  • Food & beverage$2,7003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →